首页> 外文OA文献 >A 95-gene signature stratifies recurrence risk of invasive disease in ER-positive, HER2-negative, node-negative breast cancer with intermediate 21-gene signature recurrence scores

【2h】

A 95-gene signature stratifies recurrence risk of invasive disease in ER-positive, HER2-negative, node-negative breast cancer with intermediate 21-gene signature recurrence scores

机译：A 95基因签名分层侵袭性疾病的复发风险，具有中间体21-基因签名复发评分

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Takeo Fujii; Hiroko Masuda; Yee Chung Cheng; Fei Yang; Aysegul A. Sahin; Yasuto Naoi; Yuki Matsunaga; Akshara Raghavendra; Arup Kumar Sinha; Jose Rodrigo Espinosa Fernandez; Anjali James; Keisuke Yamagishi; Tomoko Matsushima; Robert Schuetz; Debu Tripathy; Sachiyo Tada; Rubie S. Jackson; Shinzaburo Noguchi; Seigo Nakamura; Jared D. Acoba; Naoto T. Ueno;
展开▼
作者单位

展开▼
年度 2021
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Prognostic Impact of the 21-Gene Recurrence Score Assay Among Young Women With Node-Negative and Node-Positive ER-Positive/HER2-Negative Breast Cancer [J] . Poorvu Philip D., Gelber Shari I, Rosenberg Shoshana M., Journal of Clinical Oncology . 2020,第7期

机译：21-基因复发评分测定对节点阴性和节点阳性抗乳癌的少妇21-基因复发评分的预后影响
2. Comparison of efficacy of 95-gene and 21-gene classifier (Oncotype DX) for prediction of recurrence in ER-positive and node-negative breast cancer patients [J] . NaoiY., KishiK., TsunashimaR., Breast cancer research and treatment. . 2013,第2期

机译：95基因和21基因分类器（Oncotype DX）预测ER阳性和淋巴结阴性乳腺癌患者复发的疗效比较
3. Comparison of efficacy of 95-gene and 21-gene classifier (Oncotype DX) for prediction of recurrence in ER-positive and node-negative breast cancer patients [J] . NaoiY., KishiK., TsunashimaR., Breast cancer research and treatment. . 2013,第2期

机译：95-基因和21-基因分类器（Oncotype DX）对ER阳性和节点阴性乳腺癌患者复发预测的疗效比较
4. Spatio-Temporal Signatures to Predict Retinal Disease Recurrence [C] . Wolf-Dieter Vogl, Sebastian M. Waldstein, Bianca S. Gerendas, International conference on information processing in medical imaging . 2015

机译：时空特征预测视网膜疾病的复发
5. Establishing an immune gene signature for stage II cutaneous melanoma at high risk of recurrence. [D] . Sivendran, Shanthi. 2011

机译：为高复发风险的II期皮肤黑素瘤建立免疫基因标记。
6. Prognostic Impact of the 21-Gene Recurrence Score Assay Among Young Women With Node-Negative and Node-Positive ER-Positive/HER2-Negative Breast Cancer [O] . Philip D. Poorvu, Shari I. Gelber, Shoshana M. Rosenberg, -1

机译：21基因复发评分测定对淋巴结阴性和淋巴结阳性ER阳性/ HER2阴性乳腺癌的年轻女性的预后影响
7. Chemosensitivity to doxorubicin of ER-positive/HER2-negative breast cancers with high 21-gene recurrence score: A study based on in vitro chemoresponse assay. [O] . Sung Gwe Ahn, Soong June Bae, Changik Yoon, 2017

机译：对具有高21基因复发评分的ER阳性/ HER2阴性乳腺癌的阿霉素的化学敏感性：基于体外化学反应测定的研究。

A 95-gene signature stratifies recurrence risk of invasive disease in ER-positive, HER2-negative, node-negative breast cancer with intermediate 21-gene signature recurrence scores

著录项

引文网络

相似文献

相关主题

期刊订阅